Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transgenes for tea?

John Heritage1

  • 1School of Biochemistry and Microbiology, University of Leeds, Leeds, LS2 9JT, UK. j.heritage@leeds.ac.uk

Trends in Biotechnology
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

Scientific evidence shows no increased harm from consuming genetically modified (GM) plants compared to conventional ones. However, public opposition and economic factors necessitate addressing GM plant safety, gene flow, and labeling regulations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current challenges in real-world management of Clostridioides difficile infection.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Patient satisfaction with infection prevention and control interventions in acute hospitals: a systematic review and meta-analysis.

BMJ open·2025
Same author

Clostridioides difficile should be considered a bacterial priority pathogen.

The Lancet. Microbe·2025
Same author

Update on microbiota-derived therapies for recurrent Clostridioides difficile infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023
Same author

Hear my voice: involving patients in Clostridioides difficile infection research.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023
Same author

Fidelity evaluation of the dialogue around respiratory illness treatment (DART) program communication training.

Patient education and counseling·2022
Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026
Same journal

Engineering a capture-bioremediate-release microbial biofilm for simultaneous bioremediation of microplastics and adsorbed heavy metals.

Trends in biotechnology·2026
Same journal

Engineered bacterial biofilms for biotechnological applications.

Trends in biotechnology·2026
Same journal

Multiscale and programmable engineering of edible mushroom mycelium-based materials.

Trends in biotechnology·2026
Same journal

Transporter engineering in microbial cell factories.

Trends in biotechnology·2026
Same journal

Random integration and high-throughput screening forging robust microbial cell factories.

Trends in biotechnology·2026
See all related articles

Area of Science:

  • Agricultural biotechnology
  • Food safety
  • Genetics

Background:

  • Growing public concern and economic limitations surround genetically modified (GM) plants.
  • Despite widespread cultivation, scientific consensus on GM plant safety remains a topic of public discourse.

Purpose of the Study:

  • To evaluate the scientific evidence regarding the safety of consuming GM plants.
  • To address key issues impacting the adoption and regulation of GM plant technology.

Main Methods:

  • Review of existing scientific literature on animal and human consumption of GM plants.
  • Analysis of potential gene flow pathways from GM plants to other organisms.
  • Examination of current regulatory frameworks and their implications for GM crops.

Related Experiment Videos

Main Results:

  • No compelling scientific evidence indicates increased harm from consuming GM plants versus conventional counterparts.
  • Potential for transgene migration to gut microbes, animal, or human tissues requires further investigation.
  • Current legislation on GM plant labeling presents challenges.

Conclusions:

  • The scientific basis for harm from GM plant consumption is lacking.
  • Addressing public concerns, gene flow, and regulatory issues is crucial for the future of GM plant technology.
  • Further research and clear communication are needed to navigate the complexities of GM crop acceptance.